Investors Posts

Start-up vs public market investing

20th May 2021

Getting sleeves rolled up

3rd March 2021

The impact of COVID19 on seed investing

20th January 2021

The role of SEIS & EIS in a portfolio

3rd October 2020

Genius is evenly distributed, opportunity is not

14th September 2020

Post pandemic start-up valuations

18th June 2020

7 killer questions to ask an S/EIS Fund Manager

1st June 2020

When it’s risky, take risk

11th March 2020

SEIS: the ugly duckling or beautiful swan of early stage investing?

3rd March 2020

Obsessed about markets

21st January 2020

Beyond the cliché

23rd July 2019

SERENDIPITIOUS INNOVATION

8th March 2019

Our five criteria for selecting seed investments

18th December 2018

Autumn budget 2018

29th October 2018

Where seed investing fits in a portfolio

9th October 2018

A fair valuation for seed stage investments

24th August 2018

Spreading the word about EIS & SEIS

15th June 2018

The impact of portfolio investing

17th May 2018

Backing a growth market

5th March 2018

A TIME AND PLACE FOR CROWDFUNDING

6th February 2018

BUCKING THE BIAS – INVESTING IN MORE FEMALE AND REGIONAL ENTREPRENEURS

19th December 2017

5 questions for building a seed investment portfolio

20th October 2017

More similarities than differences between B2B and B2C

6th October 2017

THE PATIENT CAPITAL REVIEW

20th September 2017

Benchmarking seed investment returns

18th August 2017

The ‘world leading’ Seed Enterprise Investment Scheme

17th July 2017

Some relief from remarkable times

20th June 2017